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ABSTRACT 
Stat3 has been shown to play a role in intestinal regeneration and colitis-associated colon 
carcinogenesis. However, the role of Stat3 in the Wnt-driven sporadic intestinal tumorigenesis 
remains poorly understood. We examined the roles of Stat3 in intestinal regeneration and 
tumorigenesis by organoid culture experiments using Stat3∆IEC mouse-derived intestinal 
epithelial cells in which Stat3 was disrupted. The regeneration of intestinal mucosa and 
organoid formation were significantly suppressed by Stat3 disruption, which was compensated 
by Wnt activation. Furthermore, once organoids were recovered, Stat3 was no longer required 
for organoid growth. These results indicate that Stat3 and Wnt signaling cooperatively protect 
epithelial cells at the early phase of intestinal regeneration. In contrast, intestinal tumorigenesis 
was not suppressed by Stat3 disruption in ApcΔ716 and Apc∆716 Tgfbr2∆IEC mice, thus indicating 
that Stat3 is not required for Wnt activation-driven intestinal tumorigenesis. Mechanistically, 
Itga5 and Itga6 were downregulated by Stat3 disruption, and FAK activation was also 
suppressed. Notably, FAK inhibitor suppressed the organoid formation of wild-type epithelial 
cells. These results indicate that Stat3 is indispensable for the survival of epithelial cells 
through the activation of integrin signaling and the downstream FAK pathway; however, it is 
not required for the Wnt signaling-activated normal or tumor epithelial cells. 
 
KEY WORDS: colon cancer, organoids, anoikis, integrin, FAK,  
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INTRODUCTION 
It has been established that inflammatory responses promote cancer development and 
malignant progression (1, 2). In the inflammatory tumor microenvironment, macrophages and 
fibroblasts express cytokines and chemokines, resulting in the activation of transcription 
factors, such as NF-κB and signal transducer and activator of transcription 3 (Stat3). The 
aberrant activation of Stat3 was found in >70% of human cancers (3, 4), and Stat3 activation 
is correlated with the invasiveness, proliferation and stemness of human colon cancer cells (5-
7). Furthermore, studies using a colitis-associated colon cancer (CAC) mouse model have 
shown that the disruption of Stat3 in epithelial cells significantly suppresses CAC development 
through the suppression of proliferation and induction of apoptosis (8, 9). It has also been 
shown that IL-11 is a dominant IL-6 family cytokine in gastrointestinal tumors, and IL-11 
receptor signaling promotes tumorigenesis through Stat3 activation (10). Based on these results, 
the Stat3 pathway is thought to be an important target in the development of anti-cancer drugs 
for various cancers, including CRC (11). 
In contrast to these findings, several studies have demonstrated a tumor suppressor role 
of Stat3 in intestinal tumorigenesis (12, 13). In those reports, the disruption of Stat3 in ApcMin 
mice, a model of familial adenomatous polyposis, did not suppress tumorigenesis; instead, it 
induced the submucosal invasion of tumor cells, suggesting that Stat3 prevents the malignant 
progression of intestinal tumors. This discrepancy in the role of Stat3 in intestinal 
tumorigenesis may be due to the different mechanisms of cancer development in these models 
(i.e. inflammation and regeneration-associated tumorigenesis in the CAC model and Wnt 
activation-driven tumorigenesis in ApcMin mice). A comprehensive genome analysis indicated 
that >90% of human CRCs carry genetic alterations in APC or CTNNB1 resulting in Wnt 
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signaling activation (14); thus, it is important to investigate the precise role of Stat3 in Wnt 
activation-driven CRC development. 
The Stat3 function has been shown to be absolutely required for the intestinal stem cell 
survival (15). Consistently, Stat3 plays a role in the regeneration of the damaged intestinal 
mucosa after irradiation or DSS treatment (16, 17). However, the mechanism through which 
Stat3 signaling is involved in the stem cell survival and proliferation during regeneration has 
not been fully elucidated. Wnt/β-catenin signaling is a key driver of the tissue stem cell property, 
making the Wnt pathway important for both regeneration and cancer development (18, 19). 
Furthermore, pathways through focal adhesion kinase (FAK) or lysin methyltransferase 
SETD7 are responsible for both mucosal regeneration and tumorigenesis in the intestine 
through the activation of Wnt signaling (20, 21). However, the role of Stat3 in intestinal 
regeneration and tumorigenesis has not been studied in the context of Wnt-driven 
carcinogenesis.  
In the present study, we used genetic mouse models and organoid culture systems to show 
that Stat3 is required for the survival and proliferation of the residual stem cells in damaged 
mucosa or isolated crypts, leading to crypt formation in the regenerating mucosa as well as 
organoid formation in Matrigel. However, Stat3 is not required for crypt development when 
Wnt signaling is activated by exogenous ligand stimulation or when the Apc gene is lost. 
Consistently, Stat3 is dispensable for Wnt activation-driven tumor development and malignant 
progression, including submucosal invasion and liver metastasis. These results suggest that the 
Wnt activation status and regeneration phenotype are important factors to consider with regard 
to the efficacy of Stat3 inhibitors in the prevention of CRC development. 
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MATERIALS AND METHODS 
Mouse experiments 
Apc∆716, Stat3flox/flox and villin-CreER mice were previously described (22-24). Tgfbr2flox/flox 
mice were obtained from the Mouse Repository (NCI-Frederick, Frederick, MD, USA) (25). 
The genetic background of all strains used in this study is C57BL/6. For organoid culture 
experiments, villin-CreER Stat3flox/flox mice were treated with Tamoxifen (Tam; 4 mg/mouse, 
intraperitoneal [i.p.]) for 3 continuous days at 4-8 weeks of age, resulting in Stat3 disruption in 
the intestinal epithelial cells (hereafter, Stat3∆IEC). X-ray irradiation (9 Gy) was performed to 
induce intestinal mucosal regeneration (n=9 for wild-type mice, and n=12 for Stat3∆IEC mice). 
For the in vivo experiments, Apc∆716 villin-CreER Stat3 flox/flox mice and Apc∆716 villin-CreER 
Tgfbr2flox/flox Stat3 flox/flox mice were generated by crossing and treated with Tam (4 mg/mouse, 
i.p.) once per week from 6 to 19 weeks of age. The total number of intestinal polyps and the 
size distribution were scored under a dissection microscope (n=10 for Apc∆716 mice, n=12 for 
Apc∆716 Stat3∆IEC mice, n=10 for Apc∆716 Tgfbr2∆IEC mice, and n=8 for Apc∆716 Tgfbr2∆IEC 
Stat3∆IEC mice). Invasion frequency was scored using hematoxylin and eosin (H&E) histology 
sections (n=4 each for Apc∆716 and Apc∆716 Stat3∆IEC mice).  
The protocols for the animal experiments were approved by the Committee on Animal 
Experimentation of Kanazawa University.  
 
Organoid culture experiments 
The organoid cultures were prepared from the intestinal mucosa and tumors of the small 
intestine according to a previously described method (26). In brief, dissected tissues were 
soaked in 2 mM EDTA for 30 min, and crypts were isolated by shaking. Isolated crypts were 
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then collected and suspended in Matrigel with Advanced DMEM/F12 medium (Invitrogen, 
Carlsbad, CA, USA) supplemented with 50 ng/ml EGF (Invitrogen), 100 ng/ml Noggin 
(Peprotech, Rocky Hill, NJ, USA) and 10% R-Spondin1 conditioned medium prepared from 
human R-Spondin1-expressing 293T cells (kindly provided by Nick Barker’s lab; A-STAR, 
Singapore). For mechanical passage, 15 organoids (200 µm < φ < 400 µm) were collected using 
Cell Recovery Solution (CORNING, Corning, NY, USA), and crypt structures roughly 
dissociated into fragments by pipetting were mixed with Matrigel and transferred to 3 wells of 
a 48-well plate. For enzymatic passage, the collected organoids were dissociated by treatment 
with 25 mM trypsin for 5 min, suspended in Matrigel, and seeded at 105 cells/well (for wild-
type and Stat3∆IEC mice) or 106 cells/well (for Apc∆716 and Apc∆716 Stat3∆IEC mice) to each well 
of 48-well plate. The respective passage experiments were performed three times, and the mean 
organoid numbers were counted. For the rescue experiments, 10 µM ROCK inhibitor (Y-
27632; Wako, Osaka, Japan) and 5 µM GSK3 inhibitor (CHIR-99021; Tocris Bioscience, 
Bristol, UK) were added, and the total numbers of organoids derived from about 300 crypts 
were counted under a dissection microscope. Rescue experiments for each inhibitor 
combination were performed three times, and the mean organoid numbers were counted. For 
the activation of Wnt signaling, conditioned medium including afamin-associated Wnt3a 
(AFM-Wnt3a) was obtained from Dr. Toshiro Sato (Keio University, Japan) using a cell line 
established by Dr. Junichi Takagi (Osaka University, Japan) and added to the medium (27). The 
organoid cell proliferation was examined using the Click-iT EdU Imaging System (Invitrogen), 
and the EdU labeling index was calculated by counting the number of positive cells in at least 
five organoids. Organoids were treated with FAK inhibitor 14 (Merck, Darmstadt, Germany) 
at 15 µM.  
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Histology and immunohistochemistry 
The tissue specimens were fixed in 4% paraformaldehyde, paraffin-embedded, and cut into 4-
μm-thick sections. Crypts were isolated by ethylenediaminetetraacetic acid (EDTA), and 
organoids were fixed in 4% paraformaldehyde and embedded in iPGell (Genostaff, Tokyo, 
Japan). The sections were stained with H&E. For immunohistochemistry, antibodies against 
Ki67 (Life Technologies, Grand Island, NY, USA), CD44s (Merck, Darmstadt, Germany), 
phosphorylated Stat3 at Tyr705 (Cell Signaling, Danvers, MA, USA) and phosphorylated FAK 
at Tyr397 (Cell Signaling) were used as the primary antibodies. Staining signals were 
visualized using a Vectastain Elite Kit (Vector Laboratories, Burlingame, CA, USA). Apoptosis 
was examined using an Apoptag Peroxidase In Situ Apoptosis Detection Kit (Merck). 
 
Cell culture and transplantation experiments 
A mouse metastatic intestinal cancer cell line (AKTP) was established as recently described 
(28). AKTP cells carry Apc∆716 KrasG12D Tgfbr2-/- Trp53R270H mutations. To disrupt the Stat3 
gene in AKTP cells, Stat3-specific sgRNA was cloned into the px330 expression vector 
(Addgene), which bicistronically expresses sgRNA and Cas9 nuclease, and transfected to 
AKTP cells. The sgRNA sequence was determined by the CRSPR Design Tool 
(http://crispr.mit.edu/). Disruption of the Stat3 gene was confirmed by Western blotting using 
a Stat3 antibody (Cell Signaling). Cell proliferation was examined using a Cell Titer-Glo 2.0 
Assay (Promega Corporation, Madison, WI, USA). 
For the metastasis analysis, 1 × 106 cells were transplanted into the spleen of 
immunodeficient NOD/Shi-scid Il2rg-/- mice (NSG mice; CIEA, Kanagawa, Japan) (n=3 for 
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each cell line), and metastatic liver lesions were examined histologically at 4 weeks after 
transplantation. The efficiency of metastasis was scored by the measurement of the areas of 
metastasized foci per total liver on H&E-stained sections. 
 
Expression analyses  
Total RNA was extracted from isolated crypts using an RNeasy Plus Micro extraction kit 
(Qiagen GmbH, Hilden, Germany). An expression analysis was performed using the RT2 
Profiler PCR Array (Mouse Cell Junction Pathway Finder). 
 
Real-time reverse transcription (RT)-polymerase chain reaction (PCR)  
For the real-time RT-PCR, total RNA was extracted from isolated crypts or organoids using an 
RNeasy Plus Micro extraction kit (Qiagen GmbH, Hilden, Germany), reverse-transcribed using 
a PrimeScript RT reagent kit (Takara, Tokyo, Japan), and amplified using ExTaqII SYBR 
Premix (Takara) on a Stratagene Mx3000P real-time thermocycler (Agilent Technologies, 
Santa Clara, CA, USA). The purchased primer sequences were as follows: Itga5-
F:GAAGCTCTGAAGATGCCCTACCA, Itga5-R: TGATGATCCACAACGGGACAC; and 
Itga6-F:GTCACCGCTGCTGCTCAGAATA, Itga6-R:AGCATCAGAATCCCGGCAAG 
(TaKaRa, Shiga, Japan). 
 
Statistical analyses  
The data were analyzed using an unpaired t-test and are presented as the mean ± standard 
deviation (s.d.). P values of < 0.05 were considered to indicate statistical significance. 
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RESULTS 
Stat3 is required for the regeneration of the intestinal mucosa 
The epithelial Stat3 expression has been shown to be required for the regeneration of the 
damaged intestinal mucosa (17, 29, 30). We confirmed that phosphorylated Stat3 (P-Stat3) was 
detected in the cryptic cells of the X-ray-irradiated wild-type mouse intestine, while P-Stat3 in 
the normal intestinal epithelia was below the detection limit (Fig. 1A). These results indicate 
that the Stat3 activation is significantly increased in epithelial cells of regenerating mucosa. 
We then constructed Stat3∆IEC mice, in which Stat3 was disrupted in the intestinal epithelial 
cells in a cell-specific manner by the treatment of villin-CreER Stat3flox/flox mice with tamoxifen. 
We confirmed that P-Stat3 was not detected in the X-ray-irradiated Stat3∆IEC mouse intestine 
(Fig. 1A). X-ray irradiation caused a more severe phenotype in Stat3∆IEC mice than in wild-type 
mice; the 7-day survival rates of wild-type and Stat3∆IEC mice were 67% and 17%, respectively 
(Fig. 1B). Histologically, mucosal regeneration was significantly suppressed in Stat3∆IEC mice, 
and the number of remaining crypts at three days after irradiation in Stat3∆IEC mice was 
significantly decreased in comparison to wild-type mice (Fig. 1C, D). The numbers of Ki-67-
positive proliferating cells and CD44-positive undifferentiated cells in the residual crypts were 
also significantly decreased in the Stat3∆IEC intestinal mucosa. These results indicate that the 
activation of epithelial Stat3 is required for crypt repopulation via the survival and proliferation 
of the residual stem cells in the damaged mucosa, which leads to regeneration.  
 
Stat3 is required for intestinal organoid formation 
To understand the biological mechanism of Stat3 in the regeneration of the intestinal mucosa, 
we next examined the in vitro organoid formation of intestinal epithelial cells, which mimics 
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crypt regeneration in vivo. Intestinal cryptic cells isolated from wild-type mice formed 
organoids through the construction of mini-crypt structures in Matrigel (Fig. 2A). Importantly, 
however, intestinal cryptic cells derived from Stat3∆IEC mice failed to generate organoids in 
Matrigel. Consistently, previous reports indicated that exogenous IL-22 signaling promotes 
organoid formation and mucosal regeneration through the induction of Stat3 activation (30, 
31). Taken together, these results indicate that Stat3 activation is required for intestinal crypt 
reconstruction. 
Next, we treated isolated cryptic cells from Stat3∆IEC mice with Rho-associated protein 
kinase (ROCK) inhibitor (Y-27632) and glycogen synthase kinase 3 (GSK3) inhibitor (CHIR-
99021), as these inhibitors increase the efficiency of organoid formation through the 
suppression of anoikis and the activation of Wnt signaling, respectively (32). Notably, the 
addition of both inhibitors significantly increased the number of Stat3∆IEC mouse-derived 
organoids, while treatment with Y-27632 or CHIR-99021 alone was not sufficient for organoid 
recovery (Fig. 2A, B). We confirmed the disruption of Stat3 in the rescued organoids by Western 
blotting, which ruled out the possibility of contamination of Stat3 wild-type cells 
(Supplementary Fig. 1).  
Intriguingly, once the organoids were generated from Stat3∆IEC intestinal crypts in the 
presence of inhibitors, the rescued Stat3∆IEC organoids no longer required inhibitor treatment 
for further growth (Fig. 2C). The organoid-forming efficiency of Stat3∆IEC epithelial cells was 
unaltered compared with wild-type after mechanical passage. Furthermore, the EdU labeling 
efficiency of the rescued and mechanically passaged Stat3∆IEC organoids was similar to that of 
wild-type mouse-derived organoids (Fig. 2D). In contrast, the development of Stat3∆IEC 
organoids was significantly suppressed when the rescued organoids were passaged after 
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enzymatic dissociation by trypsin (Fig. 2E). These results suggest that Stat3 is required for 
crypt formation from the remnant stem cells in the damaged mucosa due to protection from 
anoikis, whereas Stat3 is no longer required for the maintenance and growth of the established 
crypts. It is noteworthy that the conditional Stat3 disruption in the intestinal epithelial cells of 
adult mice did not change the mucosal morphology, proliferation rate or differentiation into 
lysozymes or Muc2-expressing cells (Supplementary Fig. 2). Furthermore, the numbers of 
SOX7-positve undifferentiated cells in the Stat3∆IEC mice were similar to those in wild-type 
mice. These results support the idea that Stat3 is only necessary to generate new crypts from 
the remnant stem cells following radiation injury. 
 
Wnt activation compensates for Stat3 disruption to support organoid formation 
It has been shown that GSK3 inhibitor increases the colony formation efficiency of intestinal 
stem cells through Wnt signaling activation (32,33). Since treatment with CHIR99021 is 
required for the recovery of Stat3∆IEC organoids, it is possible that Wnt signaling activation is 
involved in the recovery of Stat3∆IEC organoid formation. To assess this possibility, we cultured 
Stat3∆IEC mouse intestinal crypts in medium supplemented with the active water-soluble form 
of lipidated Wnt3a, which is associated with bovine serum protein afamin (AFM-Wnt3a) (27). 
As expected, AFM-Wnt3a treatment increased the number and size of the organoids derived 
from wild-type mouse crypts in comparison to organoid cultures with control medium, which 
is consistent with the findings of a previous report in human intestinal organoids (27) (Fig. 3A). 
Importantly, AFM-Wnt3a treatment rescued the organoid formation of Stat3∆IEC mouse 
intestinal crypts, even in the absence of an inhibitor (Fig. 3B). These results indicate that Wnt 
signaling activation can compensate for Stat3 disruption to support the survival and 
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proliferation of isolated intestinal cryptic cells.  
We further examined whether or not Stat3 was required for organoid formation by Wnt 
signaling-activated epithelial cells using a different mouse model. Adenoma cells were isolated 
from the intestinal polyps of Apc∆716 mice and Apc∆716 Stat3∆IEC compound mice and cultured 
in Matrigel. In these tumor cells, Wnt/β-catenin signaling is constitutively activated because of 
an Apc mutation (22). When tumor cell organoids were mechanically passaged by pipetting, 
the organoids developed at the same level in both genotypes, similar to normal intestine-
derived organoids (Fig. 3C). Notably, after the enzymatic dissociation of organoids by trypsin, 
Apc∆716 Stat3∆IEC tumor cells formed organoids that were similar in total number and size 
distribution to simple Apc∆716 tumor-derived organoids. Taken together, these results indicate 
that Wnt signaling activation compensates for Stat3 disruption to support the survival and 
proliferation of the dissociated normal and tumor epithelial cells through protection from 
anoikis. 
 
Stat3 is dispensable for Wnt activation-driven intestinal tumorigenesis 
These results prompted us to examine the role of Stat3 in the Wnt activation-driven intestinal 
tumorigenesis by Apc mutations. We examined the phenotypes of Apc∆716 Stat3∆IEC mice and 
age-matched simple Apc∆716 mutant mice. P-Stat3 was detected in the nuclei of the tumor cells 
of Apc∆716 mouse polyps but not in Apc∆716 Stat3∆IEC mice, indicating that Stat3 is activated in 
the Wnt-driven sporadic tumor cells (Fig. 4A). However, there was no significant difference in 
the total number of tumors between Apc∆716 and Apc∆716 Stat3∆IEC mice (Fig. 4B). The size 
distributions of the tumors and the number of Ki67-positive cells were also similar, and no 
significant difference was found in Apc∆716 Stat3∆IEC mice. These results indicate that Stat3 is 
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dispensable for Wnt activation-driven intestinal tumorigenesis.  
Submucosal invasion was found in approximately 36% of intestinal polyps of >1 mm in 
size in the Apc∆716 Stat3∆IEC mice, while invasion was not found in simple Apc∆716 mice 
(Supplementary Fig. 3A and B), which is consistent with the previous findings in ApcMin mice 
(12,13). We confirmed that the invasion frequency was significantly different between Apc∆716 
mice and Apc∆716 Stat3∆IEC mice (Supplementary Fig. 3C). These results suggest a tumor 
suppressor role of Stat3; however, further investigations will be needed to confirm this point. 
Next, we introduced the Stat3∆IEC allele into Apc∆716 Tgfbr2∆IEC compound mice, which 
develop invasive adenocarcinomas due to a combination of Wnt activation and TGF-β 
suppression (34). Notably, nuclear-accumulated P-Stat3 was detected in the tumor cells and 
stromal cells at the invasion front of Apc∆716 Tgfbr2∆IEC mouse tumors, whereas it was detected 
only in the stroma cells of Apc∆716 Tgfbr2∆IEC Stat3∆IEC tumors (Fig. 4C). However, the total 
number of intestinal tumors and submucosal invasion efficiency in Apc∆716 Tgfbr2∆IEC and 
Apc∆716 Tgfbr2∆IEC Stat3∆IEC mice did not differ to a statistically significant extent (Fig. 4D), 
indicating that Stat3 is not required for the submucosal invasion of intestinal tumor cells. 
 
Stat3 is dispensable in Wnt activation-associated intestinal tumor metastasis 
We recently established tumor-derived organoid cells (AKTP cells) from the intestinal tumors 
of Apc∆716 KrasG12D Tgfbr2-/- Trp53R279H quadruple compound mice (28). AKTP cells 
efficiently metastasized to the liver when transplanted into the mouse spleen. To examine 
whether or not Stat3 is involved in the metastatic process of Wnt-activated CRC cells, we 
disrupted the Stat3 gene in AKTP cells using the CRISPR/Cas9 system (Fig. 5A). The 
disruption of Stat3 did not significantly change the cell proliferation rate of AKTP cells (Fig. 
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5B). Furthermore, multiple metastatic foci were developed in the livers of mice after the 
injection of two independent lines of Stat3-disrupted AKTP cells into the spleen (Stat3 KO#1 
and Stat3 KO#2), and the multiplicity did not differ from that of control AKTP cells to a 
statistically significant extent (p=0.158 and 0.201 for control vs KO#1 and KO#2, respectively) 
(Fig. 5C). Moreover, there was no significant difference in the size distributions of metastatic 
foci between control AKTP cells and Stat3 KO#1 or Stat3KO#2 cells. Histologically, we 
confirmed that Stat3 is phosphorylated in metastasized AKTP tumor cells but not in Stat3 KO 
cells; however, the Ki67 labeling efficiency of the Stat3-disrupted AKTP cells did not differ 
from that of control metastasized tumor cells (Fig. 5D). Furthermore, the expression level of 
total and active form β-catenin in Stat3-disrupted cells was similar to that of control AKTP 
cells, indicating that Wnt signaling activation is not affected by Stat3 gene disruption 
(Supplementary Fig. 4). These results indicate that Stat3 is not required for metastasis of Wnt 
activation-associated CRC cells. 
 
Stat3-induced integrin expression is associated with FAK activation in crypts 
When intestinal crypts were isolated by EDTA treatment, we realized that Stat3∆IEC mouse-
derived crypts showed a distinct morphology from the clear cylinder-like structure of wild-type 
crypts (Fig. 6A, top). We therefore examined the histology of isolated crypts that were collected 
from the intestine of wild-type and Stat3ΔIEC mice by EDTA treatment for 30 min. Notably, 
epithelial cell alignment was impaired, and apoptosis was induced in the isolated Stat3∆IEC 
crypts, while the alignment of columnar epithelial cells with the lateral expression of E-
cadherin was confirmed in the wild-type crypts (Fig. 6A). These results indicate that Stat3 is 
important for the survival of cryptic cells after isolation from intestine following detachment 
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from the extracellular matrix (ECM). 
We therefore examined the changes in the expression of cell adhesion molecules using a 
PCR array. Notably, the expression of Gjb1, Gjb2 and Gjb3, which encode the gap junction 
proteins connexin 32, 26 and 31, respectively, and Itga5 and Itga6, which encode integrins α5 
and α6, respectively, was significantly downregulated in the isolated Stat3∆IEC crypts (Fig. 6B). 
We confirmed that the expression of Itga5 and Itga6 was significantly decreased in the isolated 
Stat3∆IEC mouse intestinal crypts but not in the inhibitor-rescued Stat3∆IEC organoids by RT-
PCR (Fig. 6C). Integrin α5 and α6 bind integrin β1 to form receptor complexes for fibronectin 
and laminin, respectively. It has been shown that the signaling of these ECM components 
through integrin complexes is important for the survival of epithelial cells through their 
activation of FAK, which protects cells from anoikis after detachment from the ECM (35). 
Importantly, phosphorylated FAK (P-FAK) was detected by immunostaining in epithelial cells 
of wild-type mouse-derived crypts; however, the staining intensity for P-FAK was significantly 
decreased in the Stat3∆IEC mouse-derived cryptic cells (Fig. 6D). To examine whether or not 
FAK signaling is indeed required for the organoid formation of the isolated crypts, we treated 
cultured organoids derived from wild-type crypts and inhibitor-rescued Stat3∆IEC organoids 
with FAK inhibitor. Of note, FAK inhibition significantly suppressed organoid development in 
both genotypes (Fig. 6E, F). Taken together, these results indicate that Stat3 prevents anoikis 
of the isolated crypts that are detached from the ECM by inducing the expression of integrin, 
which is associated with the activation of the FAK pathway. 
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DISCUSSION 
It has been shown that Stat3 is required for regeneration of the damaged intestinal mucosa 
(17,23). We confirmed the role of Stat3 in intestinal regeneration as well as organoid formation 
in Matrigel, which mimics crypt formation in vitro. Importantly, however, we showed that Stat3 
is not required for the growth of established organoids and that organoids can be maintained 
indefinitely by mechanical dissociation in the absence of Stat3. In contrast, Stat3-disrupted 
organoid cells were unable to survive when organoids were enzymatically dissociated by 
trypsin. These results indicate that while Stat3 is important in the protection of intestinal 
epithelial cells from acute injury and the subsequent induction of anoikis, it is not required for 
the maintenance and proliferation of steady-state cryptic cells (Fig. 7). 
One possible mechanism underlying the impaired survival of Stat3ΔIEC epithelial cells 
after tissue damage or crypt isolation is the downregulation of integrin α5 and α6, which 
complex with integrin β1 to form the receptors for fibronectin and laminin, respectively. It has 
been shown that integrin signaling from ECM activates FAK, which is important for the 
survival of epithelial cells through the further activation of the PI3K/Akt and Ras/MEK 
signaling pathways (35). It has also been shown that signaling through α5β1 integrin protects 
the intestinal epithelial cells from apoptosis (36). Thus, Stat3-dependent integrin signaling may 
contribute to the survival of epithelial cells through the activation of FAK signaling. 
Importantly, we showed that Wnt signaling activation by an exogenous ligand 
compensated for Stat3 disruption to support organoid development. It has been shown that c-
Myc-induced FAK activation is required for mucosal regeneration downstream of the Wnt 
signaling pathway (20). It has also been shown that treatment of ApcMin mice with FAK 
inhibitor significantly suppressed intestinal polyposis (37). Accordingly, it is possible that the 
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Stat3 pathway and Wnt signaling cooperatively regulate the survival of the epithelial cells in 
the damaged mucosa and isolated crypts through the activation of integrin/FAK signaling. It 
was recently shown that subepithelial telocytes are a source of Wnt ligands for intestinal 
epithelial cells (38). It is therefore possible that such a stromal network lining the intestinal 
crypts in lamina propria is disrupted in the damaged intestinal mucosa, resulting in a decrease 
in Wnt signaling activity in regenerating epithelial cells, which may impair the stem cell 
properties of the residual stem cells. Under such Wnt-suppressed circumstances, Stat3 is 
important for the survival of epithelial cells through the activation of FAK signaling. In contrast, 
when Wnt signaling is sufficiently activated, Stat3 is not required for the survival of epithelial 
cells (Fig. 7). This hypothesis may explain why Wnt activation-driven tumor cells do not 
require Stat3 activation. 
It has been shown that Paneth cells generate a stem cell niche through Wnt ligand 
secretion (39), and IL-6-induced Stat3 activation in Paneth cells increases organoid cell 
proliferation through Wnt activation (40). Accordingly, it is also possible that suppression of 
Paneth cell-dependent Wnt signaling causes impaired regeneration and crypt formation in 
Stat3ΔIEC mice. 
With regard to the role of Stat3 in tumorigenesis, it has been shown that the blocking of 
IL-6 and IL-11 cytokine signaling or downstream transcription factor Stat3 causes the 
significant suppression of CAC development in mouse models, indicating that Stat3 is 
indispensable for inflammation-associated colonic tumorigenesis (8-10). However, we showed 
in the present study that Stat3 was not required for intestinal tumor development in ApcΔ716 
mice and that submucosal invasion was not suppressed in ApcΔ716 Tgfbr2ΔIEC mice by Stat3 
disruption. Furthermore, Stat3 is also dispensable for liver metastasis of ApcΔ716 KrasG12D 
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Tgfbr2-/- Trp53R270H tumor cells. These genetic results indicate that Stat3 does not play an 
important role in Wnt activation-driven colonic tumorigenesis or the malignant progression of 
CRC (Fig. 7); thus, its role differs from that in CAC development. Accordingly, in CAC 
development, it is possible that Stat3 is required for the survival and proliferation of tumor 
cells initiated in the ulcerative colitis mucosa, similarly to normal epithelial cells. In contrast, 
in sporadic CRC development, Wnt signaling is constitutively activated by the genetic 
alteration of APC or CTNNB1, which is sufficient to support the survival of tumor cells 
independently of the Stat3 pathway. In the present study, we showed that the epithelial Stat3 
pathway is not required for Wnt-driven tumorigenesis; however, Stat3 in stromal cells is also 
activated in the inflammatory microenvironment of intestinal tumors. Thus, it is still possible 
that stromal Stat3 plays a role in sporadic tumorigenesis. 
We also found that Stat3 disruption induced the submucosal invasion of intestinal tumors 
of ApcΔ716 mice, which is consistent with the findings of previous reports using ApcMin Stat3-/- 
compound mice (12,13). It has also been shown that Stat3 suppresses KRAS-induced lung 
tumorigenesis and p19ARF expression-associated prostate cancer metastasis (41, 42). Thus, 
Stat3 may play a tumor suppressor role in the malignant progression of CRC. However, a 
further analysis to compare the results of mouse experiments and human CRC findings is 
needed to draw hard conclusions in this regard.  
In conclusion, Stat3 is required for the survival and proliferation of the remaining 
epithelial cells in the damaged mucosa; thus, Stat3 is indispensable for mucosal regeneration 
and CAC development. In contrast, Stat3 is not required for Wnt activation-driven tumor 
development or the malignant progression of CRC (Fig. 7). Mechanistically, Wnt signaling and 
Stat3 cooperate to support the survival of cryptic epithelial cells through the activation of the 
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integrin/FAK signaling pathway, which protects epithelial cells from anoikis. When Wnt 
signaling is sufficiently activated, Stat3 is no longer required for the survival or proliferation 
of normal and tumor epithelial cells. Thus, the degree of Wnt activation in cancer cells has an 
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Figure Legends 
Figure 1. The histological analysis of the X-ray-irradiated mouse small intestine. A) 
Representative sections immunohistochemically stained for phosphorylated Stat3 (P-Stat3) in 
the small intestine of control wild-type and irradiated wild-type and irradiated Stat3ΔIEC mice. 
Bars, 100 μm. Insets indicate enlarged images of the boxed areas. B) The survival rate of wild-
type and Stat3ΔIEC mice after X-ray-irradiation (n=9 for wild-type and n=12 for Stat3∆IEC mice). 
C) Representative histology sections from wild-type (left) and Stat3ΔIEC (right) mouse 
intestines (H&E) (top) and immunohistochemical staining for Ki67 (middle) and CD44 
(bottom). Insets show enlarged image views of the boxed areas. Bars, 100 μm. D) The mean 
number of crypts in the microscopy fields (left) and Ki67-positive cells per crypt (right) are 
shown (mean ± s.d.). Asterisk, p < 0.05. 
 
Figure 2. The role of Stat3 in organoid formation from intestinal crypts. A) A schematic 
illustration of tamoxifen (Tam) treatment and organoid formation (top). Representative 
microscopic photographs of organoid cultures of intestinal crypts of wild-type and Stat3ΔIEC 
mice on day 2 (left) and day 4 (right). Arrowheads indicate organoids rescued by inhibitors (Y-
27632 and CHIR-99021). Bars, 250 μm. B) The mean numbers of organoids per well developed 
from the intestinal crypts of wild-type (top) and Stat3ΔIEC mice (bottom) in the indicated 
inhibitor conditions are shown (mean ± s.d.). Asterisk, p < 0.05; and N.S., not significant. 
Inhibitor treatment experiments were performed three times for each mouse genotype. C) A 
schematic illustration of organoid passaging by mechanical pipetting (top). Representative 
microscopic photographs of organoids passaged from wild-type and Stat3ΔIEC rescued 
organoids (bottom). Insets show enlarged views. Bars, 250 μm. The mean numbers of organoids 
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> 150 µm are shown in the bar graph (mean ± s.d.). The mechanical passage experiments were 
performed three times. D) Immunohistochemical staining of wild-type (top) and Stat3ΔIEC 
(bottom) rescued organoids for EdU (green) and E-cadherin (red). EdU labeling efficiency is 
shown in the bar graph (mean ± s.d.). N.S., not significant. E) A schematic illustration of 
organoid passaging by trypsin treatment (top). Representative microscopic photographs of 
organoids passaged from wild-type (top) and Stat3ΔIEC-rescued organoids (bottom). Bars, 200 
μm (day 0) and 1mm (day 10). The mean numbers of organoids are shown in the bar graph 
(mean ± s.d.). Asterisk, p < 0.05. The enzymatic passage experiments were performed three 
times. 
 
Figure 3. Wnt activation compensates for Stat3 disruption to support organoid formation. A) 
A schematic illustration of Tam treatment and organoid formation (top). Representative 
microscopic photographs of organoids of the intestinal crypts from wild-type mice cultured 
with control medium (top) and AFM-Wnt3a (bottom) on day 2 (left) and day 5 (right). Bars, 
250 μm. B) Representative microscopic photographs of organoid cultures of the intestinal 
crypts from Stat3ΔIEC mice cultured with control medium (top), AFM-Wnt3a without inhibitor 
(middle) and with inhibitor (bottom) on days 3 (left) and 5 (right). Bars, 250 μm. C) A 
schematic illustration of Tam treatment, tumor-derived organoid formation and treatment with 
pipetting or trypsin to passage (top). Representative microscopic photographs of the primary 
organoids (left; Bars, 250 μm) and organoids passaged by pipetting (middle; Bars, 250 μm) and 
trypsin treatment (right; Bars, 500 μm) derived from intestinal tumors of ApcΔ716 simple mutant 
mice (top) and ApcΔ716 Stat3ΔIEC compound mice (bottom). The mean numbers of organoids 
(top) and size distributions (bottom) after passaging with trypsin treatment in the respective 
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genotype are shown in the bar graphs (mean ± s.d.). N.S., not significant. The experiments 
were performed three times. 
 
Figure 4. The dispensable role of Stat3 in Wnt-driven intestinal tumorigenesis. A) A schematic 
illustration of Tam treatment of ApcΔ716 mice (n=10) and Apc∆716 villin-CreER Stat3flox/flox mice 
(n=12) (top). Representative histology sections of small intestinal tumors of ApcΔ716 mice (left) 
and ApcΔ716 Stat3ΔIEC mice (right) (H&E) (top) and immunohistochemical staining for Ki67 
(middle) and phosphorylated Stat3 (P-Stat3) (bottom). Insets show enlarged views. Bars, 200 
μm. B) The total numbers of polyps in each mouse are shown with dots with the mean values 
(top). The size distribution is shown in the bar graph (mean ± s.d.). C) A schematic illustration 
of the Tam treatment of ApcΔ716 villin-CreER Tgfbr2flox/flox mice (n=10) and ApcΔ716 villin-
CreER Tgfbr2flox/flox Stat3flox/flox mice (n=8) (top). Representative histology sections of small 
intestinal tumor of ApcΔ716 Tgfbr2ΔIEC mice (left) and ApcΔ716 Tgfbr2ΔIEC Stat3ΔIEC mice (right) 
for H&E (top) and immunohistochemical staining for P-Stat3 (bottom). Insets show enlarged 
views of boxed areas. Bars, 400 μm. D) The total numbers of polyps (top) and invasive polyps 
(bottom) per section are shown with the mean number. N.S., not significant. 
 
Figure 5. The dispensable role of Stat3 in Wnt activation-associated cancer cell metastasis. A) 
Western blotting results for Stat3 in control AKTP cells (Cont) and Stat3-targeted AKTP cell 
lines, Stat3 KO #1 and #2, by CRISPR/Cas9. β-catenin was used for internal controls. B) The 
results of the cell proliferation analysis of control and Stat3 KO#1 and #2 AKTP cells (mean ± 
s.d.). C) Control AKTP cells (Cont) and Stat3-targeted AKTP cell lines (Stat3 KO#1 and #2) 
were transplanted to the spleen of NSG mice (n=3 for each cell line). Representative 
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macroscopic photographs of mouse livers at four weeks after spleen transplantation are shown 
(top). Arrowheads indicate metastatic foci. The mean metastasis tumor areas (bottom left) and 
size distribution of metastatic foci (bottom right) on the histological sections are shown in the 
bar graphs (mean ± s.d.). N.S., not significant. D) Representative low-powered images of liver 
metastasis (H&E) (top) and high-powered images of serial sections of metastatic foci (H&E) 
and immunohistochemical staining for P-Stat3 and Ki67 (from top to bottom). Dotted lines 
indicate metastatic foci for each genotype. Insets show enlarged views inside of metastatic foci. 
Bars, 200 μm. 
 
Figure 6. The Stat3-dependent integrin expression and FAK activation. A) Representative 
photographs of isolated crypts under a dissection microscope, a histological section of isolated 
crypts (H&E), and immunohistochemical staining for E-cadherin and ApopTag (from top to 
bottom) of wild-type (left) and Stat3ΔIEC isolated intestinal crypts (right). Insets show enlarged 
views. Bars, 100 μm. B) Results of the filter array expression analysis are shown in the dot 
graph, which displays the upregulated (> 4 fold) and downregulated (< 0.25 fold) genes in the 
Stat3ΔIEC crypts in different colors. C) The relative mRNA levels in the isolated crypts (top) 
and rescued organoids (bottom) (mean ± s.d.) were examined by RT-PCR for Itega5 and Itega6. 
Asterisk, < 0.05. D) Isolated crypts from wild-type (left) and Stat3∆IEC mice (right) that were 
subjected to immunohistochemical staining for phosphorylated FAK (P-FAK). Bars, 50 μm. E) 
Representative microscopic photographs of organoids derived from wild-type (top) and 
Stat3∆IEC mouse (bottom) crypts in the absence (left) or presence (right) of FAK inhibitor in the 
Matrigel. Insets show enlarged views. Note that crypt growth was suppressed by FAK inhibitor 
regardless of genotypes. Bars, 250 μm. F) The mean numbers of developed organoids (budding 
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number > 5) in the Matrigel with or without FAK inhibitor (FAKi and NT, respectively) are 
shown (mean ± s.d.). Asterisk, p < 0.05. 
 
Figure 7. A schematic illustration of the role of Stat3 in regeneration and tumorigenesis of 
intestinal crypts. Wild-type (top) and Stat3ΔIEC crypts (bottom) are shown. Stat3 is required for 
regeneration from damaged mucosa, which may be compensated by Wnt activation (left). In 
contrast, Stat3 is dispensable for Wnt activation-driven tumorigenesis (right). 







